ICON Public Limited Company
ICON Public Limited Company (ICLR) Financial Performance & Income Statement Overview
Analyze ICON Public Limited Company (ICLR) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
ICON Public Limited Company (ICLR) Income Statement & Financial Overview
Access detailed annual and quarterly income data for ICON Public Limited Company ICLR financial performance.
Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
---|---|---|---|---|
Revenue | $2.02B | $2.001B | $2.04B | $2.03B |
Cost of Revenue | $1.55B | $1.44B | $1.44B | $1.44B |
Gross Profit | $463.88M | $558.65M | $599.37M | $591.41M |
Gross Profit Ratio | $0.23 | $0.28 | $0.29 | $0.29 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $205.006M | $198.38M | $151.44M | $205.09M |
Operating Expenses | $205.006M | $339.09M | $302.34M | $305.98M |
Total Costs & Expenses | $1.76B | $1.78B | $1.74B | $1.74B |
Interest Income | $2.05M | $1.80M | $3.008M | $2.43M |
Interest Expense | $50.15M | $47.61M | $51.43M | $53.30M |
Depreciation & Amortization | $97.72M | $95.96M | $96.66M | $93.03M |
EBITDA | $308.98M | $317.32M | $365.65M | $380.90M |
EBITDA Ratio | $0.15 | $0.16 | $0.18 | $0.19 |
Operating Income | $258.88M | $219.56M | $297.02M | $285.43M |
Operating Income Ratio | $0.13 | $0.11 | $0.15 | $0.14 |
Other Income/Expenses (Net) | -$97.76M | -$45.81M | -$48.42M | -$50.87M |
Income Before Tax | $161.11M | $173.75M | $248.60M | $234.56M |
Income Before Tax Ratio | $0.08 | $0.09 | $0.12 | $0.12 |
Income Tax Expense | -$21.86M | $19.60M | -$11.39M | $37.44M |
Net Income | $182.97M | $154.15M | $260.00M | $197.13M |
Net Income Ratio | $0.09 | $0.08 | $0.13 | $0.10 |
EPS | $2.31 | $1.89 | $3.18 | $2.38 |
Diluted EPS | $2.30 | $1.87 | $3.16 | $2.36 |
Weighted Avg Shares Outstanding | $79.25M | $81.79M | $81.79M | $82.83M |
Weighted Avg Shares Outstanding (Diluted) | $79.55M | $82.24M | $82.24M | $83.45M |
Over the past four quarters, ICON Public Limited Company demonstrated steady revenue growth, increasing from $2.03B in Q3 2024 to $2.02B in Q2 2025. Operating income reached $258.88M in Q2 2025, maintaining a consistent 13% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $308.98M, reflecting operational efficiency. Net income rose to $182.97M, with EPS at $2.31. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan